Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$134,200
-1.63%
Shares
Shares Volume: 5,000 Shares
Average Share Price: $26.84
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Aug 2 2024
traded on Aug 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 301,854 |
| PURCHASES/SALES 1Y | 0 / 12 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $106,845.32 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 3 / 38 |
| P/S VALUE RATIO | 0.309 |
| AVERAGE SALE VALUE | $402,721.18 |
| COMPANY PREVIOUS TRADES |